anti-ZNF417 antibody product blog
Tags: Antibody; Polyclonal Antibody; ZNF417; anti-ZNF417 antibody;
The ZNF417 znf417 (Catalog #MBS854276) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The ZNF417 Antibody reacts with HumanPredicted: Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s ZNF417 can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Western Blot (WB).
ELISA: 1:20,000-1:80,000
WB: 1:1,000-1:2,000. Researchers should empirically determine the suitability of the ZNF417 znf417 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The ZNF417 znf417 product has the following accession number(s) (GI #19343978) (NCBI Accession #BC025783). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given antibody. We\'ve tested the ZNF417 Antibody with the following immunoassay(s):
Testing Data
Rabbit polyclonal ZNF417 (1) antibody was raised against a recombinate human ZNF417 protein 169-425aa (BC025783).
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing ZNF417 are readily searchable from our website. Different antibodies against the same target such as ZNF417 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results. The following patways have been known to be associated with this gene.